Maximilien Fournier Sourdille
Direktor/Vorstandsmitglied bei Themis Bioscience GmbH
Aktive Positionen von Maximilien Fournier Sourdille
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Omnes Capital SAS /Venture/
Omnes Capital SAS /Venture/ Investment ManagersFinance Omnes Capital SAS /Venture/ is a Venture Capital firm, a subsidiary of Omnes Capital SAS founded in 1999. Omnes Capital /Venture/ is headquartered in Paris. | Private Equity Investor | 01.03.2019 | - |
Private-Equity-Analyst | 01.07.2017 | 01.03.2019 | |
Themis Bioscience GmbH
Themis Bioscience GmbH Pharmaceuticals: MajorHealth Technology Themis Bioscience GmbH operates as a biotechnology company, which engages in the development of prophylactic vaccinations from preclinical to early clinical phase. The firm focuses on the prevention of tropical infectious diseases. Its proprietary Themaxyn technology platform, in-licensed from Paris-based Institute Pasteur, forms the basis of all of the company's vaccine candidates. The company was founded by Erich Tauber in 2009 and is headquartered in Vienna, Austria. | Direktor/Vorstandsmitglied | - | - |
MBO+ SAS
MBO+ SAS Investment ManagersFinance Mbo & Co. Sas is an Independent Private Equity firm founded in 2002. Mbo & Co. Sas is headquartered in Paris. | Private Equity Investor | 01.09.2020 | - |
Eye Tech Care SA
Eye Tech Care SA Medical SpecialtiesHealth Technology Eye Tech Care SA develops medical devices for non-invasive eye disease treatment. It offers an ultrasound device which offers a non-invasive treatment that utilizes the ultrasound circular cyclo-coagulation procedure that reduces the intraocular pressure in refractory glaucoma. The firm serves the ophthalmology market in France and Europe. The company was founded by Fabrice Romano, Laurent Farcy and Philippe Chapuis in 2008 and is headquartered in Rillieux-la-Pape, France. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Maximilien Fournier Sourdille
Ehemalige bekannte Positionen von Maximilien Fournier Sourdille
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Thérapixel SA
Thérapixel SA Packaged SoftwareTechnology Services Thérapixel SA designs software publisher for healthcare facilities. The company was founded by Olivier Clatz and Pierre Fillard in 2013 and is headquartered in Valbonne, France. | Direktor/Vorstandsmitglied | 13.03.2019 | - |
Statistik
International
Frankreich | 5 |
Österreich | 2 |
Operativ
Director/Board Member | 3 |
Private Equity Investor | 2 |
Private Equity Analyst | 1 |
Sektoral
Finance | 3 |
Health Technology | 3 |
Technology Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 5 |
---|---|
Omnes Capital SAS /Venture/
Omnes Capital SAS /Venture/ Investment ManagersFinance Omnes Capital SAS /Venture/ is a Venture Capital firm, a subsidiary of Omnes Capital SAS founded in 1999. Omnes Capital /Venture/ is headquartered in Paris. | Finance |
Themis Bioscience GmbH
Themis Bioscience GmbH Pharmaceuticals: MajorHealth Technology Themis Bioscience GmbH operates as a biotechnology company, which engages in the development of prophylactic vaccinations from preclinical to early clinical phase. The firm focuses on the prevention of tropical infectious diseases. Its proprietary Themaxyn technology platform, in-licensed from Paris-based Institute Pasteur, forms the basis of all of the company's vaccine candidates. The company was founded by Erich Tauber in 2009 and is headquartered in Vienna, Austria. | Health Technology |
Thérapixel SA
Thérapixel SA Packaged SoftwareTechnology Services Thérapixel SA designs software publisher for healthcare facilities. The company was founded by Olivier Clatz and Pierre Fillard in 2013 and is headquartered in Valbonne, France. | Technology Services |
MBO+ SAS
MBO+ SAS Investment ManagersFinance Mbo & Co. Sas is an Independent Private Equity firm founded in 2002. Mbo & Co. Sas is headquartered in Paris. | Finance |
Eye Tech Care SA
Eye Tech Care SA Medical SpecialtiesHealth Technology Eye Tech Care SA develops medical devices for non-invasive eye disease treatment. It offers an ultrasound device which offers a non-invasive treatment that utilizes the ultrasound circular cyclo-coagulation procedure that reduces the intraocular pressure in refractory glaucoma. The firm serves the ophthalmology market in France and Europe. The company was founded by Fabrice Romano, Laurent Farcy and Philippe Chapuis in 2008 and is headquartered in Rillieux-la-Pape, France. | Health Technology |